# Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)

Study · id `cardio:ct-nct01588756` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01588756](<https://clinicaltrials.gov/study/NCT01588756>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01588756

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01588756. Non-randomized; no masking; primary purpose diagnostic. Start 2010-10 (actual); primary completion 2015-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 1/2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01588756, source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)
- Started: 2010-10 (actual) (ClinicalTrials.gov record NCT01588756, source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)
- Primary completion: 2015-05 (actual) (ClinicalTrials.gov record NCT01588756, source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)
- Completion: 2015-05 (actual) (ClinicalTrials.gov record NCT01588756, source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT01588756, source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01588756-2017-03-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
- Acronym: AcSDKP-NH2
- Condition: Healthy
- Condition: Chronic Kidney Disease
- Intervention (Drug): AcSDKP-NH2 inuline
- Intervention (Drug): AcSDKP-NH2 Cr-EDTA
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 83d1d26336d28f765148794604d369b1bbf40e4c73e1c75ac673a6ff49d7d57e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
